Literature DB >> 23384741

History of oral contraceptive drugs and their use worldwide.

Sophie Christin-Maitre1.   

Abstract

The first hormonal pill, called Enovid(®), was approved by the Federal Drug Administration (FDA) in May 1960. It contained mestranol and norethisterone. Over the years, oral contraceptives have evolved through gradual lowering of ethinyl estradiol (EE) content, introduction of 17β estradiol, and many different progestins. The standard regimen allows for 21 days of pill containing steroids and a pill-free interval of 7 days. Recently, continuous or extended regimens have been approved. In order to improve compliance, alternative routes of combined oral contraceptive (COC) administration have been developed such as vaginal or transdermal routes. In 2009, according to the United Nations, the mean global percentage using contraception in women who are married or in union was 62.7%. COC represented 8.8% of contraceptive prevalence, reaching 15.4% in more developed countries. More than 100 million women worldwide use COCs. However, each year, many unintended pregnancies occur, indicating that contraception still needs to be promoted.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23384741     DOI: 10.1016/j.beem.2012.11.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  41 in total

1.  Hormonal contraception is not associated with increased risk for seizures in the general population: results from a cohort study using The Health Improvement Network.

Authors:  Christoph Patrick Beier; Luis A García Rodríguez; María E Sáez; David Gaist; Antonio González-Pérez
Journal:  Eur J Clin Pharmacol       Date:  2018-05-31       Impact factor: 2.953

Review 2.  Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research.

Authors:  Thalia Robakis; Katherine E Williams; Lexi Nutkiewicz; Natalie L Rasgon
Journal:  Curr Psychiatry Rep       Date:  2019-06-06       Impact factor: 5.285

Review 3.  Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.

Authors:  Olivia J Hall; Sabra L Klein
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

4.  Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.

Authors:  Si Wang; Jeroen C W Rijk; Harrie T Besselink; René Houtman; Ad A C M Peijnenburg; Abraham Brouwer; Ivonne M C M Rietjens; Toine F H Bovee
Journal:  Toxicol Sci       Date:  2014-06-13       Impact factor: 4.849

Review 5.  A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives.

Authors:  Zanfina Ademi; C Simone Sutherland; Joris Van Stiphout; Jöelle Michaud; Goranka Tanackovic; Matthias Schwenkglenks
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

6.  Menstrual Irregularity, Hormonal Contraceptive Use, and Bone Stress Injuries in Collegiate Female Athletes in the United States.

Authors:  Jennifer Cheng; Kristen A Santiago; Zafir Abutalib; Kate E Temme; Ann Hulme; Marci A Goolsby; Carrie L Esopenko; Ellen K Casey
Journal:  PM R       Date:  2020-12-19       Impact factor: 2.298

Review 7.  Estrogen and thrombosis: A bench to bedside review.

Authors:  Mouhamed Yazan Abou-Ismail; Divyaswathi Citla Sridhar; Lalitha Nayak
Journal:  Thromb Res       Date:  2020-05-11       Impact factor: 3.944

Review 8.  Reproductive drugs and environmental contamination: quantum, impact assessment and control strategies.

Authors:  Harpreet Kaur; Madhu Bala; Gulshan Bansal
Journal:  Environ Sci Pollut Res Int       Date:  2018-07-23       Impact factor: 4.223

9.  Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis.

Authors:  Laura Avila; Noelle Cullinan; Michael White; Marian Gaballah; Anne Marie Cahill; Deepti Warad; Vilmarie Rodriguez; Cristina Tarango; Anna Hoppmann; Stephen Nelson; Tomas Kuhn; Tina Biss; Aaron Weiss; Michael Temple; João G Amaral; Nour Amiri; Ana C Xavier; Samuele Renzi; Leonardo R Brandão
Journal:  J Thromb Haemost       Date:  2021-04-01       Impact factor: 5.824

Review 10.  The scientific body of knowledge - Whose body does it serve? A spotlight on oral contraceptives and women's health factors in neuroimaging.

Authors:  Caitlin M Taylor; Laura Pritschet; Emily G Jacobs
Journal:  Front Neuroendocrinol       Date:  2020-09-28       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.